You are here
Drugmakers seek incentives to develop antibiotics to fight 'superbugs'
MORE than 80 pharmaceutical and diagnostic companies from around the world are calling for new economic models to spur development of badly needed new antibiotics and to fight the rising global threat of drug-resistant "superbugs."
In a declaration that is being released
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org